Patents Assigned to EXAGEN INC.
  • Patent number: 12449427
    Abstract: Methods and reagents for diagnosing, prognosing, and treating systemic lupus erythematosus (SLE) are disclosed, involving calculating an SLE risk score for a subject based on a level of each of an erythrocyte C4d (EC4d) marker, a B-cell C4d (BC4d) marker, anti-nuclear antibodies (ANA), and optional rule-out markers.
    Type: Grant
    Filed: November 23, 2022
    Date of Patent: October 21, 2025
    Assignee: Exagen Inc.
    Inventors: Thierry Dervieux, Derren Barken
  • Patent number: 12372535
    Abstract: The present invention provides methods of diagnosing and monitoring systemic lupus erythematosus.
    Type: Grant
    Filed: January 8, 2024
    Date of Patent: July 29, 2025
    Assignee: EXAGEN INC.
    Inventors: Thierry Dervieux, Cole Harris
  • Patent number: 11885812
    Abstract: Provided herein are methods of diagnosing and monitoring disease activity and response to treatment in patients having systemic lupus erythematosus using panels of biomarkers, such as at least one biomarker selected from the group consisting of B-lymphocyte-bound C4d, erythrocyte-bound C4d, platelet-bound C4d, and erythrocyte complement receptor type 1, and one further biomarker selected from the group consisting of anti-MCV antibody and anti-nuclear antibody.
    Type: Grant
    Filed: September 13, 2023
    Date of Patent: January 30, 2024
    Assignee: EXAGEN INC.
    Inventors: Thierry Dervieux, Cole Harris
  • Patent number: 11761965
    Abstract: The present invention provides methods of diagnosing and monitoring systemic lupus erythematosus.
    Type: Grant
    Filed: February 15, 2023
    Date of Patent: September 19, 2023
    Assignee: EXAGEN INC.
    Inventors: Thierry Dervieux, Cole Harris
  • Publication number: 20230194548
    Abstract: The present invention provides methods of diagnosing and monitoring systemic lupus erythematosus.
    Type: Application
    Filed: February 15, 2023
    Publication date: June 22, 2023
    Applicant: Exagen Inc.
    Inventors: Thierry Dervieux, Cole Harris
  • Patent number: 11531033
    Abstract: Methods and reagents for diagnosing, prognosing, and treating systemic lupus erythematosus (SLE) are disclosed, involving calculating an SLE risk score for a subject based on a level of each of an erythrocyte C4d (EC4d) marker, a B-cell C4d (BC4d) marker, antinuclear antibodies (ANA), anti-Smith antibodies (anti-Sm) and optional rule-out markers (SS-B/La, Scl-70, Jo-1, CENP, MCV).
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: December 20, 2022
    Assignee: Exagen Inc.
    Inventors: Thierry Dervieux, Derren Barken
  • Patent number: 11360099
    Abstract: The present invention provides methods of diagnosing and monitoring systemic lupus erythematosus.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: June 14, 2022
    Assignee: EXAGEN INC.
    Inventors: Thierry Dervieux, Cole Harris